Bone Growth Stimulators Market to reach US$ 2 bn by 2031

According to a new research study by Global Insight Services (GIS), the bone growth stimulators market is expected to grow rapidly over the next 10 years to reach a value of more than the US $2 billion by 2031.

Bone Growth stimulators are devices that are used to boost the healing process during the treatment of the ailments such as spinal fixation, and orthopedic fixation. Bone growth stimulators work on all kinds of fractures such as fresh fractures, fractures healing slowly or not at all, and fractures with an elevated risk. It can also be used as supportive therapy after surgery on a fracture and in the corrective osteotomy. Bone Growth Stimulator enhances the healing process by stimulating the production of new cells, which will allow your fracture to heal considerably faster. Bone growth stimulators are the perfect treatment approach when the patient is not comfortable with the surgical procedure and wants to avoid it. Also, as it fastens the healing process, it helps patients get back to their feet quickly. Bone growth stimulators have revolutionized the treatment of bone fractures and spinal fusions and are becoming an important tool in the healing process. Advantages over surgical procedures, faster recovery time, and increasing patient preference are factors that contribute to the growth of the bone growth stimulator market.

Request Sample Pages of this Research Report:

Global Bone Growth Stimulators Market: Key Drivers

The key factor boosting the growth of the market is the growing patient preference for non-invasive and minimally invasive surgical treatments. The demand for minimally invasive procedures has witnessed a significant increase owing to the advantages offered by these procedures over traditional treatment procedures. The key advantages of minimally invasive procedures comprise fewer complications, shorter hospitalization, less pain, smaller and more cosmetic incisions, lower risk of infections, reduced postoperative care, and quicker recovery. Minimally invasive procedures make use of advanced technologies to diagnose and treat various diseases, comprising cancer. These procedures are used as an effective approach for removing cancer tumors and lymph nodes without scarring.

Similarly, emerging markets such as China, India, Brazil, and Mexico are expected to offer significant growth opportunities in the bone growth stimulators market. Factors such as the presence of a large patient population, rising healthcare expenditure, government initiatives to support the healthcare industry, strengthening export trade, and growing awareness among physicians, surgeons, and patients about the latest treatment options for spinal fusion and bone healing are expected to boost the demand for bone growth stimulation products in these countries. In addition, owing to the significant cost advantages, many patients from developed markets are reported to travel to these emerging markets to undergo medical treatment.

Report Findings

The bone growth stimulation devices segment accounted for the bone growth stimulators market

This can be attributed to the growing geriatric population, rising preference for non-surgical treatment procedures, and growing prevalence of nonunion fractures. Adding to that, obesity, smoking, and diabetes, among other factors, can delay or inhibit bone healing after surgery or trauma. The growing incidence of these risk factors will further help the market growth.

Bone growth stimulation products are used at the time or post-surgery for stimulating the natural bone growth process

The growth of this segment can be attributed to the increasing population, the growing number of spine procedures, the established safety and efficacy of stimulators in fusion surgery, and the increasing use of bone growth stimulation products.

The hospitals & ASCs accounted for the largest share of the bone growth stimulators market

The advantages of bone growth stimulation products over their counterparts, the growing prevalence of spinal disorders, and growing awareness of bone growth stimulation products are the key factors boosting the bone growth stimulators markets for hospitals and ASC’s.

Competitive Landscape

The global bone growth stimulators market report comprises key players such as Orthofix Medical, Inc. (US), DJO Finance, LLC (US), Zimmer Biomet (US), Bioventus LLC (US), Medtronic plc (Ireland), Stryker (US), DePuy Synthes (US), Arthrex, Inc. (US), Isto Biologics (US), Terumo Corporation (Japan), Ember Therapeutics, Inc. (US), Ossatec Benelux Ltd. (Netherlands), Altis Biologics (Pty) Ltd. (South Africa), Regen Lab SA (Switzerland), ITO Co., Ltd. (Japan), Elizur Corporation (US), BTT Health GmbH (Germany), Stimulate Health Inc. (Canada), VQ OrthoCare (US), Kinex Medical Company, LLC (US), Fintek Bio-Electric Inc. (Canada), Biomedical Tissue Technologies Pty Ltd. (Germany), T-Biotechnology (Turkey), DrPRP America LLC (US), Ivy Sports Medicine, LLC (US), Glofinn Oy (Finland), and REMI GROUP (India) among others.